The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Special Situations Life Sciences Innovation Fund, startups are often financed by Grand Central Tech. The meaningful sponsors for the fund in investment in the same round are Company Ventures.
Among the most popular portfolio startups of the fund, we may highlight TMRW Life Sciences. Among the most popular fund investment industries, there are Consumer, Biotechnology. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.
The important activity for fund was in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually.
Related Funds
| Fund Name | Location |
| 4.0 Partners | California, San Francisco, United States |
| Auctus Capital | India, Maharashtra, Mumbai |
| Calian | Canada, Ontario, Ottawa |
| Creative Wings | - |
| Crown Capital Partners | Canada, Ontario, Toronto |
| Expo Live | Dubai, United Arab Emirates |
| GCP Capital Partners | New York, New York, United States |
| GreenTec Capital Partners | Frankfurt, Germany, Hessen |
| Hitron Technology | - |
| Huaxin Zhongcheng Investment | China, Guangdong, Tianjin |
| Newport Holdings | New Jersey, Red Bank, United States |
| Rosebud Finance | - |
| Tara Health Foundation | - |
| Tonghui Equity Investment Fund Management | China, Guangdong, Shenzhen |
| UNCDF | New York, New York, United States |
| Union Pacific Corporation | Nebraska, Omaha, United States |
| Vuzix | New York, Rochester, United States |
| Wuxi Linghui Chuangtou | China, Jiangsu, Wuxi Shi |
| Zhongguancun Development Frontier Enterprise Investment Fund | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TMRW Life Sciences | $105M | 20 Jul 2021 | New York, New York, United States | ||
MedAnswers | $5M | 13 Aug 2019 | Los Angeles, California, United States | ||
TMRW Life Sciences | $12M | 29 May 2019 | New York, New York, United States | ||
OOVA | $1M | 13 Mar 2019 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TMRW Life Sciences | $105M | 20 Jul 2021 | New York, New York, United States | ||
MedAnswers | $5M | 13 Aug 2019 | Los Angeles, California, United States | ||
TMRW Life Sciences | $12M | 29 May 2019 | New York, New York, United States | ||
OOVA | $1M | 13 Mar 2019 | New York, United States |
